109 related articles for article (PubMed ID: 11591745)
1. HIV envelope protein inhibits MHC class I presentation of a cytomegalovirus protective epitope.
López D; Samino Y; Koszinowski UH; Del Val M
J Immunol; 2001 Oct; 167(8):4238-44. PubMed ID: 11591745
[TBL] [Abstract][Full Text] [Related]
2. Induction of rapid apoptosis for class I MHC molecule-restricted CD8(+) HIV-1 gp160-specific murine activated CTLs by free antigenic peptide in vivo.
Nakagawa Y; Shimizu M; Norose Y; Takahashi M; Takahashi H
Int Immunol; 2013 Jan; 25(1):11-24. PubMed ID: 22945875
[TBL] [Abstract][Full Text] [Related]
3. Sequential cleavage by metallopeptidases and proteasomes is involved in processing HIV-1 ENV epitope for endogenous MHC class I antigen presentation.
López D; Gil-Torregrosa BC; Bergmann C; Del Val M
J Immunol; 2000 May; 164(10):5070-7. PubMed ID: 10799863
[TBL] [Abstract][Full Text] [Related]
4. Structural requirements for class I MHC molecule-mediated antigen presentation and cytotoxic T cell recognition of an immunodominant determinant of the human immunodeficiency virus envelope protein.
Takahashi H; Houghten R; Putney SD; Margulies DH; Moss B; Germain RN; Berzofsky JA
J Exp Med; 1989 Dec; 170(6):2023-35. PubMed ID: 2479705
[TBL] [Abstract][Full Text] [Related]
5. Broad recognition of cytotoxic T cell epitopes from the HIV-1 envelope protein with multiple class I histocompatibility molecules.
Shirai M; Pendleton CD; Berzofsky JA
J Immunol; 1992 Mar; 148(6):1657-67. PubMed ID: 1371784
[TBL] [Abstract][Full Text] [Related]
6. Molecular analysis of presentation by HLA-A2.1 of a promiscuously binding V3 loop peptide from the HIV-envelope protein to human cytotoxic T lymphocytes.
Alexander-Miller MA; Parker KC; Tsukui T; Pendleton CD; Coligan JE; Berzofsky JA
Int Immunol; 1996 May; 8(5):641-9. PubMed ID: 8671651
[TBL] [Abstract][Full Text] [Related]
7. Cytotoxic T cell repertoire selection. A single amino acid determines alternative class I restriction.
Bergmann CC; Tong L; Cua RV; Sensintaffar JL; Stohlman SA
J Immunol; 1994 Jun; 152(12):5603-12. PubMed ID: 7515908
[TBL] [Abstract][Full Text] [Related]
8. Immunization of mice with human immunodeficiency virus glycoprotein gp160 peptide 315-329 induces both class I- and class II-restricted T cells: not all T cells can respond to whole molecule stimulation.
Moore RL; Fox BS
AIDS Res Hum Retroviruses; 1993 Jan; 9(1):51-9. PubMed ID: 7678972
[TBL] [Abstract][Full Text] [Related]
9. Role of conserved regions of class I MHC molecules in the activation of CD8+ cytotoxic T lymphocytes by peptide and purified cell-free class I molecules.
Takeshita T; Kozlowski S; England RD; Brower R; Schneck J; Takahashi H; DeLisi C; Margulies DH; Berzofsky JA
Int Immunol; 1993 Sep; 5(9):1129-38. PubMed ID: 8241055
[TBL] [Abstract][Full Text] [Related]
10. Inactivation of human immunodeficiency virus (HIV)-1 envelope-specific CD8+ cytotoxic T lymphocytes by free antigenic peptide: a self-veto mechanism?
Takahashi H; Nakagawa Y; Leggatt GR; Ishida Y; Saito T; Yokomuro K; Berzofsky JA
J Exp Med; 1996 Mar; 183(3):879-89. PubMed ID: 8642292
[TBL] [Abstract][Full Text] [Related]
11. A long N-terminal-extended nested set of abundant and antigenic major histocompatibility complex class I natural ligands from HIV envelope protein.
Samino Y; López D; Guil S; Saveanu L; van Endert PM; Del Val M
J Biol Chem; 2006 Mar; 281(10):6358-65. PubMed ID: 16407287
[TBL] [Abstract][Full Text] [Related]
12. Stimulation of HIV gp120-specific cytolytic T lymphocyte responses in vitro and in vivo using a detoxified pertussis toxin vector.
Carbonetti NH; Tuskan RG; Lewis GK
AIDS Res Hum Retroviruses; 2001 Jun; 17(9):819-27. PubMed ID: 11429123
[TBL] [Abstract][Full Text] [Related]
13. Restoration of cytomegalovirus antigen presentation by gamma interferon combats viral escape.
Hengel H; Lucin P; Jonjić S; Ruppert T; Koszinowski UH
J Virol; 1994 Jan; 68(1):289-97. PubMed ID: 8254740
[TBL] [Abstract][Full Text] [Related]
14. Macrophages escape inhibition of major histocompatibility complex class I-dependent antigen presentation by cytomegalovirus.
Hengel H; Reusch U; Geginat G; Holtappels R; Ruppert T; Hellebrand E; Koszinowski UH
J Virol; 2000 Sep; 74(17):7861-8. PubMed ID: 10933693
[TBL] [Abstract][Full Text] [Related]
15. Degenerate MHC restriction reveals the contribution of class I MHC molecules in determining the fine specificity of CTL recognition of an immunodominant determinant of HIV-1 gp160 V3 loop.
Shirai M; Kozlowski S; Margulies DH; Berzofsky JA
J Immunol; 1997 Apr; 158(7):3181-8. PubMed ID: 9120272
[TBL] [Abstract][Full Text] [Related]
16. Avidity of CD8 T cells sharpens immunodominance.
Dzutsev AH; Belyakov IM; Isakov DV; Margulies DH; Berzofsky JA
Int Immunol; 2007 Apr; 19(4):497-507. PubMed ID: 17376783
[TBL] [Abstract][Full Text] [Related]
17. Molecular analysis of the same HIV peptide functionally binding to both a class I and a class II MHC molecule.
Takeshita T; Takahashi H; Kozlowski S; Ahlers JD; Pendleton CD; Moore RL; Nakagawa Y; Yokomuro K; Fox BS; Margulies DH
J Immunol; 1995 Feb; 154(4):1973-86. PubMed ID: 7530749
[TBL] [Abstract][Full Text] [Related]
18. HIV-1 envelope protein is expressed on the surface of infected cells before its processing and presentation to class II-restricted T lymphocytes.
Callahan KM; Rowell JF; Soloski MJ; Machamer CE; Siliciano RF
J Immunol; 1993 Sep; 151(6):2928-42. PubMed ID: 8376762
[TBL] [Abstract][Full Text] [Related]
19. Analysis of the mechanism for extracellular processing in the presentation of human immunodeficiency virus-1 envelope protein-derived peptide to epitope-specific cytotoxic T lymphocytes.
Nakagawa Y; Takeshita T; Berzofsky JA; Takahashi H
Immunology; 2000 Sep; 101(1):76-82. PubMed ID: 11012756
[TBL] [Abstract][Full Text] [Related]
20. Induction of HIV-1 envelope (gp120)-specific cytotoxic T lymphocyte responses in mice by recombinant CHO cell-derived gp120 is enhanced by enzymatic removal of N-linked glycans.
Doe B; Steimer KS; Walker CM
Eur J Immunol; 1994 Oct; 24(10):2369-76. PubMed ID: 7523139
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
